Granules India Limited
NDC Database

Granules India Limited

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Drug for Further Processing Bulk Ingredient
  • Total Records 95
  • Latest Marketing Date 2026-03-30
  • Data Source FDA
  • First Marketing Date 2009-05-12
All
95
View
Bulk Ingredient
42
View
Drug for Further Processing
53
View
Company Overview

Company

Granules India Limited

Country

India

Website

Visit Website

Email

mail@granulesindia.com

Social Profiles

LinkedIn X / Twitter
Company Snapshot

Granules India Limited

2nd Floor, 3rd Block, My Home Hub, Madhapur, Hyderabad- 500 081 (TG)

India

granulesindia.com/ mail@granulesindia.com View on Map
NDC Records ( 95 records )
2016
06 Dec
Drug for Further Processing NDC: 62207-001

Nonproprietary Name

Cetirizine Hydrochloride

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-001

Substance

CETIRIZINE HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2016-12-06

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2017
01 Feb
Bulk Ingredient NDC: 62207-011

Nonproprietary Name

Brinzolamide

Dosage Form

POWDER

Strength

25 kg/1

Labeler

Granules India Limited

Marketing Category

EXPORT ONLY

62207-011

Substance

BRINZOLAMIDE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2017-02-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2017
24 Oct
Bulk Ingredient NDC: 62207-012

Nonproprietary Name

Metformin Hydrochloride

Dosage Form

POWDER

Strength

50 kg/50kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-012

Substance

METFORMIN HYDROCHLORIDE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2017-10-24

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2017
30 Jun
Bulk Ingredient NDC: 62207-013

Nonproprietary Name

Penicillamine

Dosage Form

POWDER

Strength

15 kg/15kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-013

Substance

PENICILLAMINE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2017-06-30

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2021
20 Dec
Bulk Ingredient NDC: 62207-017

Nonproprietary Name

RIFAXIMIN

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-017

Substance

RIFAXIMIN

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2021-12-20

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
10 Nov
Bulk Ingredient NDC: 62207-018

Nonproprietary Name

Olmesartan Medoxomil

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-018

Substance

OLMESARTAN MEDOXOMIL

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2025-11-10

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2023
30 Aug
Bulk Ingredient NDC: 62207-020

Nonproprietary Name

RIFAXIMIN

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-020

Substance

RIFAXIMIN

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2023-08-30

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
14 Nov
Drug for Further Processing NDC: 62207-021

Nonproprietary Name

Dapagliflozin

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-021

Substance

DAPAGLIFLOZIN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-11-14

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2024
12 Apr
Bulk Ingredient NDC: 62207-022

Nonproprietary Name

Methocarbamol

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

EXPORT ONLY

62207-022

Substance

METHOCARBAMOL

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2024-04-12

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2024
04 Sep
Drug for Further Processing NDC: 62207-023

Nonproprietary Name

Panadol Optizorb Granulate

Dosage Form

GRANULE

Strength

603 mg/10001

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-023

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2024-09-04

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2024
28 Oct
Bulk Ingredient NDC: 62207-024

Nonproprietary Name

Di-tert-butyl ((S)-6-oxo-6-(((S)-1-phenylpropan-2-yl) amino) hexane-1,5-diyl) dicarbamate

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-024

Substance

LISDEXAMFETAMINE DIMESYLATE

Product Type

BULK INGREDIENT

DEA Schedule

CII

Start Marketing Date

2024-10-28

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
12 Mar
Drug for Further Processing NDC: 62207-025

Nonproprietary Name

Avatrombopag Maleate

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-025

Substance

AVATROMBOPAG MALEATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-03-12

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
01 Dec
Bulk Ingredient NDC: 62207-026

Nonproprietary Name

Empagliflozin

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-026

Substance

EMPAGLIFLOZIN

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2025-12-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2026
27 Feb
Bulk Ingredient NDC: 62207-027

Nonproprietary Name

Serdexmethylphendiate Chloride

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-027

Substance

SERDEXMETHYLPHENIDATE CHLORIDE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2026-02-27

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2025
01 Jan
Drug for Further Processing NDC: 62207-040

Nonproprietary Name

acetaminophen extra strength red

Dosage Form

TABLET

Strength

500 mg/1

Labeler

Granules India Limited

Marketing Category

EXPORT ONLY

62207-040

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-01-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
01 Jan
Drug for Further Processing NDC: 62207-044

Nonproprietary Name

Acetaminophen

Dosage Form

TABLET

Strength

500 mg/1

Labeler

Granules India Limited

Marketing Category

EXPORT ONLY

62207-044

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-01-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
01 Jan
Drug for Further Processing NDC: 62207-050

Nonproprietary Name

Acetaminophen Extra Strength

Dosage Form

TABLET

Strength

500 mg/1

Labeler

Granules India Limited

Marketing Category

EXPORT ONLY

62207-050

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-01-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
02 Jan
Drug for Further Processing NDC: 62207-078

Nonproprietary Name

Acetaminophen

Dosage Form

TABLET

Strength

500 mg/1

Labeler

Granules India Limited

Marketing Category

EXPORT ONLY

62207-078

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-01-02

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2009
22 Oct
Drug for Further Processing NDC: 62207-100

Nonproprietary Name

Acetaminophen Directly compressible granules 90%

Dosage Form

POWDER

Strength

90 mg/100mg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-100

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2009-10-22

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2017
16 Aug
Drug for Further Processing NDC: 62207-101

Nonproprietary Name

Compresso PAP 90 CPF

Dosage Form

POWDER

Strength

90 mg/100mg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-101

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2017-08-16

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2021
23 Jul
Drug for Further Processing NDC: 62207-144

Nonproprietary Name

Metformin HCl

Dosage Form

POWDER

Strength

97 mg/100mg

Labeler

Granules India Limited

Marketing Category

EXPORT ONLY

62207-144

Substance

METFORMIN HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2021-07-23

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2013
29 Oct
Drug for Further Processing NDC: 62207-167

Nonproprietary Name

Acetaminophen

Dosage Form

CAPSULE, GELATIN COATED

Strength

499.5 mg/1

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-167

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2013-10-29

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2019
05 Nov
Drug for Further Processing NDC: 62207-200

Nonproprietary Name

Compresso PAP 90 CPC

Dosage Form

POWDER

Strength

90 mg/100mg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-200

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2019-11-05

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2009
12 May
Drug for Further Processing NDC: 62207-202

Nonproprietary Name

Acetaminophen Directly compressible granules 90%

Dosage Form

POWDER

Strength

90 mg/100mg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-202

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2009-05-12

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2013
04 Oct
Drug for Further Processing NDC: 62207-204

Nonproprietary Name

Acetaminophen Directly compressible granules 90%

Dosage Form

POWDER

Strength

89.605 mg/89.605mg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-204

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2013-10-04

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
01 Jan
Drug for Further Processing NDC: 62207-234

Nonproprietary Name

acetaminophen

Dosage Form

TABLET, EXTENDED RELEASE

Strength

650 mg/1

Labeler

Granules India Limited

Marketing Category

EXPORT ONLY

62207-234

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-01-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2011
16 Feb
Drug for Further Processing NDC: 62207-300

Nonproprietary Name

Ibuprofen Directly compressible granules 66%

Dosage Form

POWDER

Strength

66 mg/100mg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-300

Substance

IBUPROFEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2011-02-16

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2019
01 Nov
Drug for Further Processing NDC: 62207-303

Nonproprietary Name

COMPRESSO IBU 85 PAR

Dosage Form

POWDER

Strength

85 mg/100mg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-303

Substance

IBUPROFEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2019-11-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2015
14 Sep
Drug for Further Processing NDC: 62207-311

Nonproprietary Name

Ibuprofen Directly compressible granules 66%

Dosage Form

POWDER

Strength

66 mg/100mg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-311

Substance

IBUPROFEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2015-09-14

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2011
01 Jan
Drug for Further Processing NDC: 62207-365

Nonproprietary Name

Ibuprofen

Dosage Form

TABLET

Strength

200 mg/1

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-365

Substance

IBUPROFEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2011-01-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2011
01 Jan
Drug for Further Processing NDC: 62207-366

Nonproprietary Name

Ibuprofen

Dosage Form

TABLET

Strength

200 mg/1

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-366

Substance

IBUPROFEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2011-01-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2017
17 Aug
Drug for Further Processing NDC: 62207-400

Nonproprietary Name

Compresso MF 95P

Dosage Form

POWDER

Strength

95 mg/100mg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-400

Substance

METFORMIN HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2017-08-17

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2021
25 Mar
Drug for Further Processing NDC: 62207-416

Nonproprietary Name

Metformin Hcl

Dosage Form

POWDER

Strength

500 mg/kg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-416

Substance

METFORMIN HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2021-03-25

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2021
25 Mar
Drug for Further Processing NDC: 62207-417

Nonproprietary Name

Metformin-Hcl

Dosage Form

POWDER

Strength

750 mg/kg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-417

Substance

METFORMIN HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2021-03-25

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2017
17 Aug
Drug for Further Processing NDC: 62207-500

Nonproprietary Name

Guaifenesin Directly compressible granules 95%

Dosage Form

POWDER

Strength

95 mg/100mg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-500

Substance

GUAIFENESIN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2017-08-17

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2012
04 May
Drug for Further Processing NDC: 62207-503

Nonproprietary Name

Guaifenesin Directly compressible Granules 95%

Dosage Form

POWDER

Strength

95 mg/100mg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-503

Substance

GUAIFENESIN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2012-05-04

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2023
30 Aug
Drug for Further Processing NDC: 62207-588

Nonproprietary Name

Acetaminophen and Ibuprofen

Dosage Form

TABLET

Strength

250; 125 mg/1; mg/1

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-588

Substance

ACETAMINOPHEN; IBUPROFEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2023-08-30

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2010
10 Feb
Drug for Further Processing NDC: 62207-600

Nonproprietary Name

Acetaminophen 80% and Diphenhydramine Hcl 4% Directly compressible granules

Dosage Form

POWDER

Strength

80; 4 mg/100mg; mg/100mg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-600

Substance

ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2010-02-10

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
24 Dec
Drug for Further Processing NDC: 62207-615

Nonproprietary Name

Trazodone Hydrochloride (Common Lubricated Blend)

Dosage Form

GRANULE

Strength

0.05 kg/kg

Labeler

Granules India Limited

Marketing Category

EXPORT ONLY

62207-615

Substance

TRAZODONE HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-12-24

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2023
27 Nov
Drug for Further Processing NDC: 62207-623

Nonproprietary Name

Fexofenadine Hydrochloride

Dosage Form

TABLET

Strength

180 mg/1

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-623

Substance

FEXOFENADINE HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2023-11-27

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2014
05 Dec
Drug for Further Processing NDC: 62207-661

Nonproprietary Name

Acetaminophen and Diphenhydramine Hydrochloride

Dosage Form

TABLET

Strength

500; 25 mg/1; mg/1

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-661

Substance

ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2014-12-05

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2014
14 Jan
Drug for Further Processing NDC: 62207-664

Nonproprietary Name

Acetaminophen and Diphenhydramine Hydrochloride

Dosage Form

CAPSULE

Strength

500; 25 mg/1; mg/1

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-664

Substance

ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2014-01-14

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2013
11 Apr
Drug for Further Processing NDC: 62207-702

Nonproprietary Name

Compresso PAP 90CPF

Dosage Form

POWDER

Strength

90 mg/100mg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-702

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2013-04-11

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2019
15 Nov
Drug for Further Processing NDC: 62207-705

Nonproprietary Name

Methocarbomal Granules DC 90%

Dosage Form

POWDER

Strength

90 mg/100mg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-705

Substance

METHOCARBAMOL

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2019-11-15

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2013
24 Oct
Drug for Further Processing NDC: 62207-711

Nonproprietary Name

Compresso MF 95P

Dosage Form

POWDER

Strength

95 mg/100mg

Labeler

Granules India Limited

Marketing Category

EXPORT ONLY

62207-711

Substance

METFORMIN HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2013-10-24

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2016
11 May
Bulk Ingredient NDC: 62207-714

Nonproprietary Name

Methocarbamol Granules DC 90%

Dosage Form

POWDER

Strength

90 mg/1001

Labeler

Granules India Limited

Marketing Category

EXPORT ONLY

62207-714

Substance

METHOCARBAMOL

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2016-05-11

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2021
25 May
Drug for Further Processing NDC: 62207-725

Nonproprietary Name

Potassium chloride

Dosage Form

POWDER

Strength

50 kg/50kg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-725

Substance

POTASSIUM CHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2021-05-25

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2024
02 Apr
Drug for Further Processing NDC: 62207-740

Nonproprietary Name

Losartan Potassium Tabs 25 mg, 50 mg and 100mg (common blend)

Dosage Form

GRANULE

Strength

0.0333 kg/kg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-740

Substance

LOSARTAN POTASSIUM

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2024-04-02

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2014
12 Mar
Drug for Further Processing NDC: 62207-761

Nonproprietary Name

Naproxen Sodium

Dosage Form

TABLET, FILM COATED

Strength

220 mg/1

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-761

Substance

NAPROXEN SODIUM

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2014-03-12

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2014
12 Mar
Drug for Further Processing NDC: 62207-762

Nonproprietary Name

Naproxen Sodium

Dosage Form

TABLET, FILM COATED

Strength

220 mg/1

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-762

Substance

NAPROXEN SODIUM

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2014-03-12

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2020
12 Jun
Drug for Further Processing NDC: 62207-930

Nonproprietary Name

Paracetamol

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-930

Substance

ACETAMINOPHEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-06-12

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2018
15 May
Bulk Ingredient NDC: 62207-931

Nonproprietary Name

Metformin Hydrochloride

Dosage Form

POWDER

Strength

50 kg/50kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-931

Substance

METFORMIN HYDROCHLORIDE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2018-05-15

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2021
17 Dec
Bulk Ingredient NDC: 62207-932

Nonproprietary Name

Guaifenesin

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

EXPORT ONLY

62207-932

Substance

GUAIFENESIN

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2021-12-17

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2020
12 Jun
Bulk Ingredient NDC: 62207-933

Nonproprietary Name

Acetaminophen

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

EXPORT ONLY

62207-933

Substance

ACETAMINOPHEN

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2020-06-12

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
14 Apr
Bulk Ingredient NDC: 62207-934

Nonproprietary Name

Paracetamol Ph.Eur

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-934

Substance

ACETAMINOPHEN

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2025-04-14

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2013
01 Apr
Bulk Ingredient NDC: 62207-950

Nonproprietary Name

Guaifenesin

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

EXPORT ONLY

62207-950

Substance

GUAIFENESIN

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2013-04-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2017
11 Aug
Bulk Ingredient NDC: 62207-951

Nonproprietary Name

Metformin Hydrochloride

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-951

Substance

METFORMIN HYDROCHLORIDE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2017-08-11

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2011
31 Mar
Bulk Ingredient NDC: 62207-952

Nonproprietary Name

Methocarbamol

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

EXPORT ONLY

62207-952

Substance

METHOCARBAMOL

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2011-03-31

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2021
25 Mar
Bulk Ingredient NDC: 62207-970

Nonproprietary Name

METOPROLOL

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-970

Substance

METOPROLOL SUCCINATE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2021-03-25

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2021
06 Apr
Bulk Ingredient NDC: 62207-972

Nonproprietary Name

BORTEZOMIB

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-972

Substance

BORTEZOMIB

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2021-04-06

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2021
06 Apr
Bulk Ingredient NDC: 62207-973

Nonproprietary Name

DASATINIB

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-973

Substance

DASATINIB

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2021-04-06

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2021
06 Apr
Bulk Ingredient NDC: 62207-974

Nonproprietary Name

PRAZOSIN HYDROCHLORIDE

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-974

Substance

PRAZOSIN HYDROCHLORIDE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2021-04-06

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2021
06 Apr
Bulk Ingredient NDC: 62207-975

Nonproprietary Name

VIGABATRIN

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-975

Substance

VIGABATRIN

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2021-04-06

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2021
25 Mar
Bulk Ingredient NDC: 62207-976

Nonproprietary Name

BUPROPION

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-976

Substance

BUPROPION HYDROCHLORIDE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2021-03-25

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2021
09 Aug
Bulk Ingredient NDC: 62207-977

Nonproprietary Name

Pazopanib Hydrochloride

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-977

Substance

PAZOPANIB HYDROCHLORIDE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2021-08-09

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2023
17 Jul
Drug for Further Processing NDC: 62207-979

Nonproprietary Name

Esomeprazole Magnesium Trihydrate

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-979

Substance

ESOMEPRAZOLE MAGNESIUM TRIHYDRATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2023-07-17

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2023
12 Jul
Bulk Ingredient NDC: 62207-980

Nonproprietary Name

Lapatinib Ditosylate

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-980

Substance

LAPATINIB DITOSYLATE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2023-07-12

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2023
17 Jul
Drug for Further Processing NDC: 62207-985

Nonproprietary Name

Levetiracetam

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-985

Substance

LEVETIRACETAM

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2023-07-17

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2024
05 Mar
Bulk Ingredient NDC: 62207-986

Nonproprietary Name

DASATINIB Monohydrate

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-986

Substance

DASATINIB

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2024-03-05

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2024
05 Mar
Bulk Ingredient NDC: 62207-987

Nonproprietary Name

Linagliptin

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-987

Substance

LINAGLIPTIN

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2024-03-05

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2024
05 Mar
Bulk Ingredient NDC: 62207-988

Nonproprietary Name

Eltrombopag Olamine

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-988

Substance

ELTROMBOPAG OLAMINE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2024-03-05

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
07 Jul
Drug for Further Processing NDC: 62207-989

Nonproprietary Name

Viloxazine Hydrochloride

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-989

Substance

VILOXAZINE HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-07-07

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
07 Jul
Drug for Further Processing NDC: 62207-990

Nonproprietary Name

Ruxolitinib Hydrochloride

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-990

Substance

RUXOLITINIB HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-07-07

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
07 Jul
Drug for Further Processing NDC: 62207-991

Nonproprietary Name

Ruxolitinib Phosphate

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-991

Substance

RUXOLITINIB PHOSPHATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-07-07

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
01 Dec
Drug for Further Processing NDC: 62207-992

Nonproprietary Name

Sodium Oxybate

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-992

Substance

SODIUM OXYBATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

CI

Start Marketing Date

2025-12-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
26 Dec
Drug for Further Processing NDC: 62207-993

Nonproprietary Name

Potassium Oxybate

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-993

Substance

POTASSIUM OXYBATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-12-26

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
26 Dec
Drug for Further Processing NDC: 62207-994

Nonproprietary Name

Calcium Oxybate

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-994

Substance

CALCIUM OXYBATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-12-26

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2025
01 Dec
Drug for Further Processing NDC: 62207-995

Nonproprietary Name

Magnesium Oxybate

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-995

Substance

MAGNESIUM OXYBATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-12-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2026
30 Mar
Bulk Ingredient NDC: 62207-996

Nonproprietary Name

Gabapentin

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Limited

Marketing Category

BULK INGREDIENT

62207-996

Substance

GABAPENTIN

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2026-03-30

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2018
12 Jun
Bulk Ingredient NDC: 62207-002

Nonproprietary Name

Fexofenadine Hydrochloride

Dosage Form

POWDER

Strength

25 kg/25kg

Labeler

Granules India Ltd

Marketing Category

BULK INGREDIENT

62207-002

Substance

FEXOFENADINE HYDROCHLORIDE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2018-06-12

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2018
18 Jun
Bulk Ingredient NDC: 62207-003

Nonproprietary Name

Dimethyl Fumarate

Dosage Form

POWDER

Strength

25 kg/25kg

Labeler

Granules India Ltd

Marketing Category

BULK INGREDIENT

62207-003

Substance

DIMETHYL FUMARATE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2018-06-18

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2018
20 Feb
Bulk Ingredient NDC: 62207-004

Nonproprietary Name

Pirfenidone

Dosage Form

POWDER

Strength

25 kg/25kg

Labeler

Granules India Ltd

Marketing Category

BULK INGREDIENT

62207-004

Substance

PIRFENIDONE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2018-02-20

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2018
11 Jun
Drug for Further Processing NDC: 62207-005

Nonproprietary Name

Atazanavir Sulfate

Dosage Form

POWDER

Strength

25 kg/25kg

Labeler

Granules India Ltd

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-005

Substance

ATAZANAVIR SULFATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2018-06-11

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2018
09 Jul
Bulk Ingredient NDC: 62207-006

Nonproprietary Name

Omeprazole Magnesium

Dosage Form

POWDER

Strength

25 kg/25kg

Labeler

Granules India Ltd

Marketing Category

BULK INGREDIENT

62207-006

Substance

OMEPRAZOLE MAGNESIUM

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2018-07-09

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2018
09 Apr
Bulk Ingredient NDC: 62207-007

Nonproprietary Name

Losartan Potassium

Dosage Form

POWDER

Strength

25 kg/25kg

Labeler

Granules India Ltd

Marketing Category

BULK INGREDIENT

62207-007

Substance

LOSARTAN POTASSIUM

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2018-04-09

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2018
13 Sep
Bulk Ingredient NDC: 62207-009

Nonproprietary Name

Levocetirizine dihydrochloride

Dosage Form

POWDER

Strength

25 kg/25kg

Labeler

Granules India Ltd

Marketing Category

BULK INGREDIENT

62207-009

Substance

LEVOCETIRIZINE DIHYDROCHLORIDE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2018-09-13

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2017
24 Oct
Bulk Ingredient NDC: 62207-012

Nonproprietary Name

Metformin Hydrochloride

Dosage Form

POWDER

Strength

50 kg/50kg

Labeler

Granules India Ltd

Marketing Category

BULK INGREDIENT

62207-012

Substance

METFORMIN HYDROCHLORIDE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2017-10-24

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2023
16 Jan
Bulk Ingredient NDC: 62207-019

Nonproprietary Name

Trazodone Hydrochloride

Dosage Form

POWDER

Strength

25 kg/25kg

Labeler

Granules India Ltd

Marketing Category

BULK INGREDIENT

62207-019

Substance

TRAZODONE HYDROCHLORIDE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2023-01-16

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2022
24 Mar
Drug for Further Processing NDC: 62207-354

Nonproprietary Name

ibuprofen

Dosage Form

TABLET, FILM COATED

Strength

400 mg/1

Labeler

Granules India Ltd

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-354

Substance

IBUPROFEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-03-24

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2022
24 Mar
Drug for Further Processing NDC: 62207-355

Nonproprietary Name

ibuprofen

Dosage Form

TABLET, FILM COATED

Strength

600 mg/1

Labeler

Granules India Ltd

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-355

Substance

IBUPROFEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-03-24

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2022
24 Mar
Drug for Further Processing NDC: 62207-356

Nonproprietary Name

ibuprofen

Dosage Form

TABLET, FILM COATED

Strength

800 mg/1

Labeler

Granules India Ltd

Marketing Category

DRUG FOR FURTHER PROCESSING

62207-356

Substance

IBUPROFEN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-03-24

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2022
19 May
Bulk Ingredient NDC: 62207-981

Nonproprietary Name

Pantoprazole Sodium Sesquihydrate

Dosage Form

POWDER

Strength

15 kg/15kg

Labeler

Granules India Ltd

Marketing Category

BULK INGREDIENT

62207-981

Substance

PANTOPRAZOLE SODIUM

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2022-05-19

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2023
01 Aug
Bulk Ingredient NDC: 62207-982

Nonproprietary Name

Sorafenib Tosylate

Dosage Form

POWDER

Strength

1 kg/kg

Labeler

Granules India Ltd

Marketing Category

BULK INGREDIENT

62207-982

Substance

SORAFENIB TOSYLATE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2023-08-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2023
09 Jan
Bulk Ingredient NDC: 62207-983

Nonproprietary Name

Omeprazole

Dosage Form

POWDER

Strength

20 kg/20kg

Labeler

Granules India Ltd

Marketing Category

BULK INGREDIENT

62207-983

Substance

OMEPRAZOLE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2023-01-09

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2022
30 Sep
Bulk Ingredient NDC: 62207-984

Nonproprietary Name

Nilotinib Hydrochloride Monohydrate

Dosage Form

POWDER

Strength

600 g/600g

Labeler

Granules India Ltd

Marketing Category

BULK INGREDIENT

62207-984

Substance

NILOTINIB HYDROCHLORIDE MONOHYDRATE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2022-09-30

End Marketing Date

-

Listing Record Certified Through

2026-12-31

Related Databases
  • FDA Inspections
    20 View
  • EDQM CEP
    31 View
  • KDMF
    0 View
  • Japan DMF
    2 View
  • Eudra GMP
    0 View
  • NDC Database
    95 View
  • FDA Approved Drugs Database
    83 View
NDC Type Breakdown
95 total
  • Drug for Further Processing
  • Bulk Ingredient
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

62207-001

Nonproprietary Name

Cetirizine Hydrochloride

Labeler

Granules India Limited

Dosage Form

POWDER

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit